Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group

PURPOSE: To audit the visual acuity (VA) outcomes achieved at the end of year two in 17 UK centres, which followed the year 1 VIEW protocol in year 1, but a variable approach in year 2 for aflibercept for neovascular macular degeneration (nAMD). PATIENTS AND METHODS: Retrospective data analysis, fro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eye (Lond)
Autors principals: Almuhtaseb, H, Johnston, R L, Talks, J S, Lotery, A J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5684449/
https://ncbi.nlm.nih.gov/pubmed/28622328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.108
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars